Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: a prospective, multicenter study.

@article{Meucci2012PrognosticSO,
  title={Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: a prospective, multicenter study.},
  author={Gianmichele Meucci and Renato Fasoli and Simone Saibeni and Daniela Valpiani and Renzo Gullotta and Enrico Colombo and Renata D'inc{\'a} and Maddalena Terpin and Giovanni Lombardi},
  journal={Inflammatory bowel diseases},
  year={2012},
  volume={18 6},
  pages={1006-10}
}
BACKGROUND It has been recommended that the treatment of active ulcerative colitis (UC) should be continued until complete healing of endoscopic lesions. However, the evidence supporting this recommendation is scanty. Aims of the present study were to assess the rate of patients with active UC who achieve clinical but not endoscopic remission after treatment with oral plus topical mesalazine and to compare the rate of relapse in patients with clinical/endoscopic remission and those with only… CONTINUE READING